Comparable stake leader
Kira Sheinerman
SEC ownership of Niki BioSolutions, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001734005.
Disclosed value leader
Justin Che Yuen Wu
Comparable rows
1/4
Latest evidence
22 Jul 2026
- Public ticker
- NIKI on Nasdaq
- Parsed ownership sources
-
3/4/5 and 13D/G
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Kira Sheinerman
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
1 of 4
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Kira Sheinerman
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
22 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001734005
- Issuer location
- Princeton, NJ
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Niki BioSolutions, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Kira Sheinerman
Disclosed value leader
Justin Che Yuen Wu
Comparable rows
1/4
Latest evidence
22 Jul 2026
3/4/5
13D/G
Lead comparable stake: 52%
3 rows are not safely comparable across share classes.
13D/G row: Kira Sheinerman
Quick read
Kira Sheinerman leads the comparable SEC ownership view at 52%.
1 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Kira Sheinerman's linked filing trail.
Comparable ownership
Top 1
Kira Sheinerman
52%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-4 of 4 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Kira Sheinerman |
3/4/5
13D/G
Director, 10%+ Owner · Kira S. Sheinerman
|
52%
Reported 13D/G
· 20 Jul 2026
|
—
1,523,293 shares
mixed-class rows
|
— | 22 Jul 2026 |
| Justin Che Yuen Wu |
3/4/5
Director
|
—
denominator unverified
|
$18,631
1,832 shares
|
— | 20 Jul 2026 |
| Douglas W. Arner |
3/4/5
Director
|
—
denominator unverified
|
$10,801
1,062 shares
|
— | 20 Jul 2026 |
| Laura A. Philips |
3/4/5
Director
|
—
mixed-class rows
|
—
14,024 shares
mixed-class rows
|
— | 22 Jul 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 01 Nov 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-5 of 5 reporting-owner rows connected to Niki BioSolutions, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
5
Largest Forms 3/4/5 holder
Justin Che Yuen Wu
Net 12M change
$0
Latest report
22 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Justin Che Yuen Wu | Director | $18,631 | Mixed | 20 Jul 2026 | ||
| Douglas W. Arner | Director | $10,801 | Mixed | 20 Jul 2026 | ||
| Kira Sheinerman | Director, 10%+ Owner | Mixed | 22 Jul 2026 | |||
| Laura A. Philips | Director | Mixed | 22 Jul 2026 | |||
| Alidad Mireskandari | President, & COO | Mixed | 20 Jul 2026 |
Recent insider transactions for Niki BioSolutions, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Laura A. Philips | NIKI | Stock Options | Award | 8,000 | 8,000 | 22 Jul 2026 | Direct | |||
| Kira Sheinerman | NIKI | Stock Options | Award | 8,000 | 8,000 | 22 Jul 2026 | Direct | |||
| Kira Sheinerman | NIKI | Stock Options | Award | 8,000 | 8,000 | 22 Jul 2026 | Direct |
* marks a reported price that did not pass the local price check.